Phathom Pharmaceuticals (PHAT) announced the appointment of Ted Schroeder to its Board of Directors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Phathom Pharmaceuticals Announces Leadership Transition in 2025
- Phathom Pharmaceuticals appoints Basta as President, CEO
- Phathom Pharmaceuticals partners with Kenan Thompson for GERD awareness
- Biotech Alert: Searches spiking for these stocks today
- Phathom Pharmaceuticals: Favorable Risk/Reward Profile Amid Challenges and Growth Opportunities